Sun Pharmaceutical Industries Limited - Product Pipeline Review - 2014

Published: Mar, 2014 | Pages: 44 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Sun Pharmaceutical Industries Limited - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Sun Pharmaceutical Industries Limited - Product Pipeline Review - 2014', provides an overview of the Sun Pharmaceutical Industries Limited's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Sun Pharmaceutical Industries Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Sun Pharmaceutical Industries Limited including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Sun Pharmaceutical Industries Limited's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Sun Pharmaceutical Industries Limited's pipeline products

Reasons to buy

- Evaluate Sun Pharmaceutical Industries Limited's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Sun Pharmaceutical Industries Limited in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Sun Pharmaceutical Industries Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Sun Pharmaceutical Industries Limited and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Sun Pharmaceutical Industries Limited
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Sun Pharmaceutical Industries Limited and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Sun Pharmaceutical Industries Limited Snapshot 5
Sun Pharmaceutical Industries Limited Overview 5
Key Information 5
Key Facts 5
Sun Pharmaceutical Industries Limited - Research and Development Overview 6
Key Therapeutic Areas 6
Sun Pharmaceutical Industries Limited - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Sun Pharmaceutical Industries Limited - Pipeline Products Glance 11
Sun Pharmaceutical Industries Limited - Late Stage Pipeline Products 11
Phase III Products/Combination Treatment Modalities 11
Sun Pharmaceutical Industries Limited - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
Sun Pharmaceutical Industries Limited - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Discovery Products/Combination Treatment Modalities 15
Sun Pharmaceutical Industries Limited - Drug Profiles 16
baclofen ER 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
IP-033 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
latanoprost 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Sun-0597 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
SUN-1334 H 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
docetaxel 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
SUN-09 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
SUN-09 Slow Release 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
SUN-44 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Sun-K706 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
SUN-L731 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Therapeutics For Ocular Diseases 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Sun Pharmaceutical Industries Limited - Pipeline Analysis 31
Sun Pharmaceutical Industries Limited - Pipeline Products by Target 31
Sun Pharmaceutical Industries Limited - Pipeline Products by Route of Administration 33
Sun Pharmaceutical Industries Limited - Pipeline Products by Molecule Type 34
Sun Pharmaceutical Industries Limited - Pipeline Products by Mechanism of Action 35
Sun Pharmaceutical Industries Limited - Recent Pipeline Updates 37
Sun Pharmaceutical Industries Limited - Dormant Projects 38
Sun Pharmaceutical Industries Limited - Company Statement 39
Sun Pharmaceutical Industries Limited - Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Sun Pharmaceutical Industries Limited - Key Manufacturing Facilities 42
Appendix 43
Methodology 43
Coverage 43
Secondary Research 43
Primary Research 43
Expert Panel Validation 43
Contact Us 44
Disclaimer 44

List of Tables
Sun Pharmaceutical Industries Limited, Key Information 5
Sun Pharmaceutical Industries Limited, Key Facts 5
Sun Pharmaceutical Industries Limited - Pipeline by Indication, 2014 8
Sun Pharmaceutical Industries Limited - Pipeline by Stage of Development, 2014 9
Sun Pharmaceutical Industries Limited - Monotherapy Products in Pipeline, 2014 10
Sun Pharmaceutical Industries Limited - Phase III, 2014 11
Sun Pharmaceutical Industries Limited - Phase II, 2014 12
Sun Pharmaceutical Industries Limited - Phase I, 2014 13
Sun Pharmaceutical Industries Limited - Preclinical, 2014 14
Sun Pharmaceutical Industries Limited - Discovery, 2014 15
Sun Pharmaceutical Industries Limited - Pipeline by Target, 2014 32
Sun Pharmaceutical Industries Limited - Pipeline by Route of Administration, 2014 33
Sun Pharmaceutical Industries Limited - Pipeline by Molecule Type, 2014 34
Sun Pharmaceutical Industries Limited - Pipeline Products by Mechanism of Action, 2014 36
Sun Pharmaceutical Industries Limited - Recent Pipeline Updates, 2014 37
Sun Pharmaceutical Industries Limited - Dormant Developmental Projects,2014 38
Sun Pharmaceutical Industries Limited, Other Locations 40
Sun Pharmaceutical Industries Limited, Subsidiaries 41
Sun Pharmaceutical Industries Limited, Key Manufacturing Facilities 42